U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C22H31NO3
Molecular Weight 357.4864
Optical Activity UNSPECIFIED
Defined Stereocenters 10 / 10
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of SONGORINE

SMILES

[H][C@@]12C[C@]3([C@H](O)C1=C)[C@@]4([H])C[C@@]5([H])[C@@]6([C@@H](O)CC[C@@]5(C)CN(CC)[C@]46[H])[C@]3([H])CC2=O

InChI

InChIKey=CBOSLVQFGANWTL-DVPYZRQCSA-N
InChI=1S/C22H31NO3/c1-4-23-10-20(3)6-5-17(25)22-15(20)7-13(18(22)23)21-9-12(11(2)19(21)26)14(24)8-16(21)22/h12-13,15-19,25-26H,2,4-10H2,1,3H3/t12-,13+,15-,16-,17+,18-,19-,20+,21+,22+/m1/s1

HIDE SMILES / InChI

Molecular Formula C22H31NO3
Molecular Weight 357.4864
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 9 / 10
E/Z Centers 0
Optical Activity UNSPECIFIED

Songorine is a diterpenoid alkaloid which can be isolated from the genus Aconitum. Songorin has demonstrated anti-inflammatory, anti-anxiolytic and the ability to promote wound healing. The Anti-anxiolytic properties appear to be linked to the agonistic activity of the Dopamine D2 receptor as shown in rat hippocampal slices. The wound healing effect is the result of songorine's ability to stimulate the development of mesenchymal progenitor cells, although the exact mechanism of action remains unclear.

CNS Activity

Curator's Comment: referenced study was conducted in rat

Originator

Curator's Comment: Faculty of Pharmaceutical Sciences, University of Tokyo

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
19.6 µM [IC50]
Target ID: P61169
Gene ID: 24318.0
Gene Symbol: Drd2
Target Organism: Rattus norvegicus (Rat)
Conditions
PubMed

PubMed

TitleDatePubMed
Role of NF-κB/IKK-dependent signaling in functional stimulation of mesenchymal progenitor cells by alkaloid songorine.
2015 Mar
Involvement of PI3K, MAPK ERK1/2 and p38 in Functional Stimulation of Mesenchymal Progenitor Cells by Alkaloid Songorine.
2015 May
Role of JNK and Involvement of p53 in Stimulation of Growth Potential Realization of Mesenchymal Precursor Cells by Alkaloid Songorine.
2015 Nov
Role of cAMP- and IKK-2-Dependent Signaling Pathways in Functional Stimulation of Mesenchymal Progenitor Cells with Alkaloid Songorine.
2015 Sep
Patents

Sample Use Guides

In Vivo Use Guide
Curator's Comment: the referenced study was conducted on rat
In pharmacokinetic study, rats were administered 5.0 mg/kg intravenously
Route of Administration: Intravenous
In Vitro Use Guide
Rat hippocampal slices (400 micro-m thick) were submerged in a brain slice recording chamber immersed flowing ACSF (32 deg-C, 3-4 mL/min). Stimulus-evoked population spikes and field e.p.s.p.'s were recorded with electrodes in the stratum pyramidale and stratum radiatum area of CA1, respectively. Songorine stock was dissolved in DMSO at a concentration of 1 mM. Experimental concentrations between 1 - 100 micro-M were prepared by dilution with ACSF. At concentrations between 10 -100 micro-M songorine induced a concentration-dependent increase in the amplitude of the orthodromic population spike and of the field e.p.s.p. The effect was not reversed by 90 min of washout. However, Songorine did not affect the size and shape of the presynaptic fiber spike indicating that the enhancement of the synaptic response is not a consequence of increased afferent excitability. The antidromically evoked population spike was no affected by songorine at concentrations up to 100 micro-M suggesting that the enhancement of the orthodromic population spike and of the field e.p.s.p. was not due to an increase in pyramidal cell excitability. The inclusion of the NMDA receptor antagonist (D-AP5) did not alter the effects of songorine. However, both dopamine D2 receptor antagonists Sulpride (0.1 micro-M) and Haloperidol (10 micro M) abolished the songorine effect. The effects of Songorine were closely mimicked by the dopamine releaser, amantadine (100 mM). Finally, the effects of songorine were unaltered by the inclusion of the selective D1 receptor antagonist, SCH23390. These results suggest that songorine enhances excitatory synaptic transmission which may be due to an agonist action at D2 receptors.
Substance Class Chemical
Created
by admin
on Sat Dec 16 07:52:26 GMT 2023
Edited
by admin
on Sat Dec 16 07:52:26 GMT 2023
Record UNII
64E5D8C741
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
SONGORINE
MI  
Common Name English
SONGORIN
Common Name English
NAPELLONIN
Common Name English
XUAN-WU 2
Common Name English
BULLATINE G
Common Name English
(3R,6S,6AR,6BR,9R,11R,11AR,12R,12AR,14R)-1-ETHYLDODECAHYDRO-6,11-DIHYDROXY-3-METHYL-10-METHYLENE-12,3,6A-ETHANYLYLIDENE-9,11A-METHANOAZULENO(2,1-B)AZOCIN-8(9H)-ONE
Systematic Name English
ZONGORINE
Common Name English
12,3,6A-ETHANYLYLIDENE-9,11A-METHANOAZULENO(2,1-B)AZOCIN-8(9H)-ONE, 1-ETHYLDODECAHYDRO-6,11-DIHYDROXY-3-METHYL-10-METHYLENE-, (3R,6S,6AR,6BR,9R,11R,11AR,12R,12AR,14R)-
Systematic Name English
12,3,6A-ETHANYLYLIDENE-9,11A-METHANOAZULENO(2,1-B)AZOCIN-8(9H)-ONE, 1-ETHYLDODECAHYDRO-6,11-DIHYDROXY-3-METHYL-10-METHYLENE-, (3R-(3.ALPHA.,6.BETA.,6A.ALPHA.,6B.ALPHA.,9.BETA.,11.ALPHA.,11A.BETA.,12.ALPHA.,12A.BETA.,14R*))-
Systematic Name English
(1.ALPHA.,15.BETA.)-21-ETHYL-1,15-DIHYDROXY-4-METHYL-16-METHYLENE-7,20-CYCLOVEATCHAN-12-ONE
Common Name English
NAPELLONINE
Common Name English
SONGORINE [MI]
Common Name English
Code System Code Type Description
EPA CompTox
DTXSID001318628
Created by admin on Sat Dec 16 07:52:26 GMT 2023 , Edited by admin on Sat Dec 16 07:52:26 GMT 2023
PRIMARY
FDA UNII
64E5D8C741
Created by admin on Sat Dec 16 07:52:26 GMT 2023 , Edited by admin on Sat Dec 16 07:52:26 GMT 2023
PRIMARY
CAS
509-24-0
Created by admin on Sat Dec 16 07:52:26 GMT 2023 , Edited by admin on Sat Dec 16 07:52:26 GMT 2023
PRIMARY
PUBCHEM
71456946
Created by admin on Sat Dec 16 07:52:26 GMT 2023 , Edited by admin on Sat Dec 16 07:52:26 GMT 2023
PRIMARY
MERCK INDEX
m10113
Created by admin on Sat Dec 16 07:52:26 GMT 2023 , Edited by admin on Sat Dec 16 07:52:26 GMT 2023
PRIMARY Merck Index